FDA Releases Draft Guidance on Internet/Social Media Platforms for Prescription Drugs and Medical Devices

Summary

The US Food and Drug Administration (FDA) has published a draft guidance document outlining its expectations for pharmaceutical companies to present both benefits and risks of their prescription drugs and medical devices on digital platforms with limited character space, such as the internet and social media.